Fuse Medical, Inc. (FZMD)
OTCMKTS · Delayed Price · Currency is USD
0.0215
0.00 (0.00%)
At close: Jul 28, 2026
Fuse Medical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
| 2 | 11 | 30 | 13 | 21 | 36 | |
Market Cap Growth | -78.46% | -65.07% | 128.72% | -37.33% | -41.67% | - |
Enterprise Value | - | 12 | 30 | 14 | 22 | 36 |
Last Close Price | 0.02 | 0.15 | 0.43 | 0.19 | 0.30 | 0.50 |
Price Ratios
Fiscal Year | Current | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
PE Ratio | 0.45 | 3.41 | - | - | - | 9.13 |
PS Ratio | 0.08 | 0.57 | 1.48 | 0.62 | 0.92 | 1.37 |
PB Ratio | -6.71 | -33.93 | -8.80 | -6.25 | -17.24 | 24.63 |
P/FCF Ratio | 83.41 | 303.12 | - | 61.15 | - | 14.81 |
P/OCF Ratio | 83.41 | 303.12 | - | 55.79 | - | 14.56 |
EV Ratios
Fiscal Year | Current | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
EV/Sales Ratio | - | 0.67 | 1.48 | 0.63 | 0.96 | 1.38 |
EV/FCF Ratio | - | 357.39 | - | 62.82 | - | 14.95 |
Financial Efficiency
Fiscal Year | Current | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Debt / Equity Ratio | -9.59 | -7.55 | -0.81 | -0.84 | -1.56 | 1.11 |
Debt / FCF Ratio | 119.14 | 67.45 | - | 8.22 | - | 0.67 |
Net Debt / Equity Ratio | -8.49 | -7.07 | -0.65 | -0.28 | -0.66 | 0.53 |
Net Debt / EBITDA Ratio | 8.10 | -3.24 | -1.05 | -0.64 | -0.24 | -0.41 |
Net Debt / FCF Ratio | 105.55 | 63.20 | -1.25 | 2.72 | -40.04 | 0.32 |
Asset Turnover | 0.96 | 0.98 | 1.14 | 1.20 | 1.13 | 1.27 |
Inventory Turnover | 0.66 | 0.78 | 1.08 | 1.17 | 1.24 | 1.23 |
Quick Ratio | 0.31 | 0.34 | 0.41 | 0.78 | 0.80 | 0.85 |
Current Ratio | 1.06 | 1.11 | 1.29 | 1.74 | 1.79 | 2.41 |
Return on Equity (ROE) | - | - | - | - | -2712.32% | - |
Return on Assets (ROA) | 0.35% | -2.68% | -7.68% | -3.59% | -10.53% | -5.91% |
Return on Invested Capital (ROIC) | 1.49% | -10.28% | -23.69% | -9.98% | -53.94% | -28.98% |
Return on Capital Employed (ROCE) | 1.50% | -11.10% | -26.30% | -10.10% | -32.80% | -13.00% |
Yields
Fiscal Year | Current | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Earnings Yield | 255.75% | 29.37% | -5.26% | -10.85% | -15.74% | 10.96% |
FCF Yield | 1.20% | 0.33% | -5.89% | 1.64% | -0.10% | 6.75% |
Buyback Yield / Dilution | -16.12% | -10.72% | -0.14% | - | 5.01% | -279.62% |